Canada markets closed

Medicure Inc. (MPH.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
1.1000+0.1100 (+11.11%)
At close: 11:23AM EST

Medicure Inc.

2-1250 Waverley Street
Winnipeg, MB R3T 6C6
Canada
204 487 7412
https://www.medicure.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Dr. Albert David Friesen Ph.D.Founder, CEO & Chairman of the board330.75kN/A1947
Dr. Neil Owens Ph.D.Pres & COO166.67kN/AN/A
Mr. David Aaron Gurvey B.Sc., CMA, CPAChief Financial OfficerN/AN/A1966
Ms. Jamie GowrylukVP of Commercial OperationsN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia; and ReDS, a non-invasive medical device that offers measurement of lung fluid for the management of congestive heart failure, as well as Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. The company was founded in 1997 and is headquartered in Winnipeg, Canada.

Corporate Governance

Medicure Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.